This section contains medical information and is intended for healthcare professionals only.
Back to client websiteCOVID-19
Study conducted at Shamir (Assaf Harofeh) Medical Center - Sagol Center for Hyperbaric Medicine and Research, demonstrates that Hyperbaric oxygen therapy (HBOT) can induce neuroplasticity and improve cognitive, psychiatric, fatigue, sleep and pain symptoms of patients suffering from post-COVID-19 condition. HBOT’s beneficial effect may be attributed to increased brain perfusion and neuroplasticity in regions associated with cognitive and emotional roles.
Data and Studies from The Sagol Center
-
Effects of hyperbaric oxygen therapy on functional and structural connectivity in post-COVID-19 condition patients: A randomized, sham-controlled trial
NeuroImage: Clinical, Volume 36, 2022, 103218
-
Hyperbaric oxygen therapy improves neurocognitive functions and symptoms of post-COVID condition: randomized controlled trial
Scientific Reports volume 12, Article number: 11252 (2022)
-
Hyperbaric Oxygen Therapy for COVID-19 Patients: A Prospective, Randomized Controlled Trial
9 Apr 2021
More Studies
-
Observational study on the benefit of a nutritional supplement, supporting immune function and energy metabolism, on chronic fatigue associated with the SARS-CoV-2 post-infection progress
Clinical Nutrition Aspen, 6 September, 2021
-
Characteristics and predictors of acute and chronic post-COVID syndrome: A systematic review and meta-analysis
Elsivier, 22 May, 2021
-
Proposed subtypes of post-COVID-19 syndrome (or long-COVID) and their respective potential therapies
Medical Virology, 9 December 2021